MedPath

Fenestrated AAA Endovascular Graft Post-Approval Study

Not Applicable
Completed
Conditions
Abdominal Aortic Aneurysm (AAA)
Juxtarenal Aneurysm
Aorto-iliac Aneurysm
Interventions
Device: Zenith® Fenestrated AAA Endovascular Graft
Registration Number
NCT01990950
Lead Sponsor
Cook Research Incorporated
Brief Summary

This post-market study is approved by the US FDA to evaluate the long-term safety and performance of the Zenith® Fenestrated AAA Endovascular Graft.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • abdominal aortic and aortoiliac aneursyms with a diameter greater than or equal to 5 cm
  • aortic or aortoiliac aneurysm with a history of growth greater than or equal to 0.5 cm per year, or clinical indication for AAA repair
Exclusion Criteria
  • proximal neck less than 4mm or greater than or equal to 15 mm in length unless otherwise compromised to preclude seal
  • renal artery stenosis greater than 50 percent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Zenith® Fenestrated AAA Endovascular GraftZenith® Fenestrated AAA Endovascular Graft-
Primary Outcome Measures
NameTimeMethod
Treatment Success : AAA Related Mortality5 years

patients treated with the Zenith® Fenestrated AAA Endovascular Graft will have a rate of aneurysm-related mortality at 5 years that meets a performance goal of 18% ,

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (6)

Borgess Research Institute

🇺🇸

Kalamazoo, Michigan, United States

Newark Beth Israel Medical Center

🇺🇸

Newark, New Jersey, United States

University of California-Davis

🇺🇸

Sacramento, California, United States

University of Colorado

🇺🇸

Aurora, Colorado, United States

Wake Forest University Health

🇺🇸

Winston-Salem, North Carolina, United States

University of Wisconsin Hospital and Clinics

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath